MEDICAL DISCOVERIES INC
10QSB, EX-27, 2001-01-18
PHARMACEUTICAL PREPARATIONS
Previous: MEDICAL DISCOVERIES INC, 10QSB, EX-10.1, 2001-01-18
Next: MATERIAL SCIENCES CORP, SC 13G/A, 2001-01-18



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
financial statements contained in the body of the accompanying Form 10-QSB and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           2,207
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 2,207
<PP&E>                                          83,506
<DEPRECIATION>                                  77,563
<TOTAL-ASSETS>                                   8,150
<CURRENT-LIABILITIES>                        2,623,512
<BONDS>                                              0
                                0
                                          0
<COMMON>                                     9,913,837
<OTHER-SE>                                (12,416,699)
<TOTAL-LIABILITY-AND-EQUITY>                     8,150
<SALES>                                          7,620
<TOTAL-REVENUES>                                 7,620
<CGS>                                            2,511
<TOTAL-COSTS>                                  226,447
<OTHER-EXPENSES>                                55,884
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (277,222)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (277,222)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (277,222)
<EPS-BASIC>                                      .01
<EPS-DILUTED>                                      .01


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission